Check Aptus Pharma IPO Subscription Day 2

Click and Sign Up to Get Latest Updates on Aptus Pharma IPO 

Here, the Aptus Pharma IPO launched on 23rd September 2025. The issue will be closed for bidding today, on 25th September 2025. The primary aim of the Aptus Pharma IPO is to raise ₹13.02 crores from the market. Additionally, the Aptus Pharma IPO has received an impressive level of subscription, which suggests that the shares will be listed at a remarkable premium. Scroll down to check the Aptus Pharma IPO subscription and details. 

Aptus Pharma IPO Details 

The price band for the Aptus Pharma IPO has been prescribed as ₹65 to ₹70 per share, with a total of 18,60,000 shares to be issued. Let’s segregate the share quota fixed for different categories of investors. 

Aptus Pharma IPO Subscription Status

As of now, the Aptus Pharma IPO has been subscribed to 3.17 times. Of these, 3.99 times are subscribed by retail investors, 5.47 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of the Aptus Pharma IPO listing on 30th September 2025. Aptus Pharma also has a positive outlook behind the fresh issue of 0.19 crore shares, which is expected to raise around Rs 13.02 crore.

About Aptus Pharma Limited

Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. The company manufactures and distributes a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.

Technical Indicators

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of Aptus Pharma Limited.

Aptus Pharma IPO Listing Expectations

The Aptus Pharma IPO allotment is still pending. However, according to current GMP or market sentiments, it is reasonable to expect higher listing gains from the share. A 10.00% jump in Aptus Pharma IPO GMP indicates that the estimated listing price per share will be approximately Rs 7.

It will provide higher listing gains to investors who applied for this IPO. Additionally, the financial fundamentals of this business made it the experts’ top long-term recommendation. 

Aptus Pharma IPO GMP Today

We know that higher subscription prices encourage grey market premiums for IPOs. Let’s explore the Aptus Pharma IPO GMP for 24th September 2025. 

The grey market premium for this IPO is 10.00%, or Rs 7 per share. It indicates that the estimated listing price per share is Rs 77. Numerous factors played a pivotal role in this jump in the Aptus Pharma IPO GMP. These include higher subscription rates received, positive market sentiments, and investors’ positive attitude towards IPOs. 

Aptus Pharma IPO Dates

Note: IPO GMP is highly volatile, influenced by market sentiment. Hence, one should conduct their research before investing in it.

Download Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025

Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

Dev Accelerator IPO GMP & Review: Apply or Avoid?

Vigor Plast India IPO Listing Preview: What to Expect Now?

Krupalu Metals IPO GMP: Day 3 IPO Live Updates